Arora S, Arora R C, Garg R K, Agarwal N, Nautiyal A
Department of Obstetrics & Gynaecology, M.L.B. Medical College, Jhansi.
Indian J Physiol Pharmacol. 1988 Jan-Mar;32(1):67-71.
We studied the effects of oral contraceptive pills (OCP) supplied by the Govt of India in its Family Welfare Campaign, on serum lipid levels of women. The OCP, containing 30 micrograms ethinyl estradiol and 1 mg of norethisterone acetate were administered to the women for six months continuously and serum lipid levels were estimated after three and six months of the treatment. There were no significant changes in serum cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL), serum triglycerides and very low density lipoprotein (VLDL). In a simultaneous study we also measured serum lipid levels at 3 and 6 months after withdrawal of the pills in women who had been receiving OCP containing 50 micrograms of ethinyl estradiol and 0.5 mg of one of the progesterones for the past 1 1/2 to 2 years continuously. Only serum LDL level fell significantly (P less than 0.01) on 3 months withdrawal period. It is concluded that 6 months of usage of the OCP marketed by the Govt. of India does not affect the serum lipid profile.
我们研究了印度政府在其家庭福利运动中提供的口服避孕药(OCP)对女性血脂水平的影响。将含有30微克炔雌醇和1毫克醋酸炔诺酮的OCP连续给予女性六个月,并在治疗三个月和六个月后评估血脂水平。血清胆固醇、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、血清甘油三酯和极低密度脂蛋白(VLDL)均无显著变化。在一项同步研究中,我们还测量了在过去1.5至2年中持续服用含有50微克炔雌醇和0.5毫克一种孕激素的OCP的女性停药3个月和6个月后的血脂水平。仅在停药3个月时血清LDL水平显著下降(P小于0.01)。结论是,印度政府销售的OCP使用6个月不会影响血脂谱。